Randomized Double Blind Placebo Controlled PK/PD Study on the Effects of a Single Intravenous Dose of NOX-H94 on Serum Iron During Experimental Human Endotoxemia

Trial Profile

Randomized Double Blind Placebo Controlled PK/PD Study on the Effects of a Single Intravenous Dose of NOX-H94 on Serum Iron During Experimental Human Endotoxemia

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Sep 2014

At a glance

  • Drugs Lexaptepid pegol (Primary)
  • Indications Endotoxinaemia
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors NOXXON Pharma AG
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 28 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top